Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
HRSA Funding Opportunities: Improving Health Outcomes for People Aging with HIV
From HRSA's HIV/AIDS Bureau
News Article updated on 10/28/2021 -
Responding to an HIV Cluster or Outbreak: Who do you call? What do you do?
Model approaches for community partner engagement and coordination to support interventions for the mitigation of HIV outbreaks.Resource updated 04/07/2023
-
Elevating Consumer Voices
Building consumer leadership skills and strategies to help ensure and amplify consumer input into PC/PB activities.Resource updated 01/05/2024
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Performance Measurement: Using Data to Achieve EHE Goals
The use of performance measures to help achieve EHE plan goals.Resource updated 04/07/2023
-
Online Course on Integrated Planning
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
ESCALATE Glossary of Terms
The purpose of the ESCALATE training program is to facilitate transformative and relational change in Ryan White HIV/AIDS Programs (RWHAP) and the communities they serve. This is a Glossary of commonly used terms under in the ESCALATE capacity-building initiative.
Resource updated 05/14/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Hepatitis C Screening and Treatment Expansion
The HIV clinic at Washington University integrated comprehensive hepatitis C virus (HCV) screening and treatment into its care model. Chronic HCV is a “silent” infection as it damages the liver over time, often without symptoms. Early treatment of HCV is particularly important among people with HIV, as HIV accelerates HCV’s progression. Of the 1,711 clients served at the clinic each year, 174 had a detectable HCV viral load. These clients received integrated clinical and support services to reduce barriers to ongoing HCV care engagement.Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
-
ESCALATE en español
ESCALATE capacita y empodera a participantes para reconocer y abordar el estigma del VIH dentro de cada nivel del programa Ryan White de VIH/SIDA (RWHAP, por sus siglas en inglés). ESCALATE contará con la participación de equipos de reducción del estigma (un mínimo de dos equipos participantes) dentro de las 57 jurisdicciones identificadas en la iniciativa Terminar con la epidemia de VIH: un plan para Estados Unidos (EHE, por sus siglas en inglés) con un enfoque particular en la reducción del estigma en las personas transgénero o de género no binario y hombres que tienen sexo con hombres. El programa también se enfocará en miembres de comunidades Negra/Africana Americana, latinx, comunidades india americanas y nativas de Alaska. NMAC trabaja en colaboración con Abt Associates, TRX Development y NORC de la Universidad de Chicago.Organization updated 07/11/2024
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
ELEVATE en español
El programa ELEVATE tiene como objetivo desarrollar la capacidad de las personas con VIH para que participen de forma significativa en la planificación, prestación y mejoramiento de los servicios del Programa Ryan White de VIH/SIDA (RWHAP, por sus siglas en inglés).Organization updated 07/11/2024
-
ELEVATE: Let’s Talk About It-HIV
Review of key HIV related terminology and the basic biology of HIV and the stages of HIV infection.Resource updated 02/28/2023